BridgeMD
New treatment option for Alzheimer Disease
Official title CONSTELLATIONS Living Lab: Improving the Care Transitions of Older Adults Living with Neurocognitive Disorders
ClinicalTrials.gov ID: NCT06608589
What this study is testing
- What it's testing
- The prevalence of major neurocognitive disorders (MNCDs), particularly Alzheimer's disease, among older adults is increasing. These individuals and their caregivers often face challenges due to inefficient and poorly coordinated care transitions, negatively impacting patients, caregivers, healthcare professionals, and the healthcare system itself.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Study population for the evaluation of the impact of the CoMPAS+ MNCD Program on the care transitions of patients living with MNCD and their...
- Be 65 years of age or older;
- Be living with a major neurocognitive disorder in the process of clinical evaluation or already diagnosed;
- Reside in the socio-sanitary region of the CISSS CA;
- Be able to consent independently to research (for users without caregivers at the beginning of their illness);
You likely can't join if
- Users living with major neurocognitive disorder under 65 years of age;
- User living in a provincial long-term care facility at the time of recruitment;
- User 65 years of age and older living with a major neurocognitive disorder, unable to consent independently to research, without a caregiver, or...
- Users aged 65 and over living with a major neurocognitive disorder, residing in a territory other than that of the CISSS CA;
- User refusing to consent to the collection of data in their medical records; OR
- Caregiver of a user living with a major neurocognitive disorder who does not reside in the CISSS CA territory or who is not 65 years of age or does...
See the full eligibility criteria
Who can join
- Study population for the evaluation of the impact of the CoMPAS+ MNCD Program on the care transitions of patients living with MNCD and their caregivers (Micro level)
- Be 65 years of age or older;
- Be living with a major neurocognitive disorder in the process of clinical evaluation or already diagnosed;
- Reside in the socio-sanitary region of the CISSS CA;
- Be able to consent independently to research (for users without caregivers at the beginning of their illness);
- Reside at home or in a retirement home or in an intermediate residence or a family-type resources;
- Consent to the research team collecting data in their medical records (FMG Electronic Medical Record (EMR) when accessible, Hospital Electronic Patient Record (EPR) when accessible, etc.). OR
- Be the caregiver of a person 65 years of age and older living with a major neurocognitive disorder in the process of clinical evaluation or already diagnosed;
- The person being cared for must reside in the socio-sanitary region of the CISSS CA;
- Consent to the research team collecting data from the medical records of the person being cared for (FMG Electronic Medical Record (EMR) when accessible, Hospital Electronic Patient Record (EPR) when accessible, etc.);
- Be able to consent independently to research.
What rules you out
- Users living with major neurocognitive disorder under 65 years of age;
- User living in a provincial long-term care facility at the time of recruitment;
- User 65 years of age and older living with a major neurocognitive disorder, unable to consent independently to research, without a caregiver, or without a caregiver able to consent independently to research;
- Users aged 65 and over living with a major neurocognitive disorder, residing in a territory other than that of the CISSS CA;
- User refusing to consent to the collection of data in their medical records; OR
- Caregiver of a user living with a major neurocognitive disorder who does not reside in the CISSS CA territory or who is not 65 years of age or does not live at home, in a retirement home or in an IR or who died before...
- Caregiver refusing to consent to the collection of data in the medical records of the person being cared for. Study population for the assessment of the intention to apply best practices of CoMPAS+ MNCD workshop...
- Be a participant in the CoMPAS+ MNCD workshops and be part of at least one of the following categories of participants:
- Health professionals working in a CISSS CA health facility or with a community organization;
- CISSS CA decision-makers or local managers;
- Community service representative (e.g., Alzheimer's Society, L'APPUI); Exclusion criteria:
- Research team members
- Workshop facilitators
- INESSS professionals
- Users and partner caregivers
- Person unable to consent
- Person refusing to consent Study population for the evaluation of the potential to scale-up and sustainability of the CoMPAS+ MNCD Program within the CISSS CA (Meso level) Inclusion criteria
- Be part of one of the following categories of actors and be involved in the implementation of the CoMPAS+ MNCD Program:
- Health professionals working at the CISSS CA or in the community participating in the CoMPAS+ MNCD workshops;
- CISSS CA decision-makers;
- Users and partner caregivers;
- Community service representatives (e.g., Alzheimer's Society, L'APPUI);
- Members of the research team (except the person in charge of this component (Laetitia Bert), Alexander Cornea (research assistant), Martyne Audet (scientific coordinator), Clémence Dallaire, André Côté, Félix Pageau...
- Research coordinator responsible for the involvement of partner users in the conduct of the workshops (Émilie Côté);
- INESSS professionals;
- Workshop facilitators
- Representative of the Ministry of Health and Social Services (MSSS). Exclusion criteria
- Person unable to consent;
- A person refusing to consent;
- Member of the research team responsible for carrying out this part of the study or by the scientific coordination of this project (Laetitia Bert, Alexander Cornea, Martyne Audet (scientific coordinator), Clémence...
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Quebec, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.